Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventMay 18, 2001Open Report of unscheduled material events or corporate event in HTML.Open Report of unscheduled material events or corporate event in DOC file.Open Report of unscheduled material events or corporate event in PDF file.Open Report of unscheduled material events or corporate event in XLS file.
10-QQuarterly report which provides a continuing view of a company's financial positionMay 10, 2001Open Quarterly report which provides a continuing view of a company's financial position in HTML.Open Quarterly report which provides a continuing view of a company's financial position in DOC file.Open Quarterly report which provides a continuing view of a company's financial position in PDF file.Open Quarterly report which provides a continuing view of a company's financial position in XLS file.
DEFA14AAdditional proxy soliciting materials - definitiveApr 18, 2001Open Additional proxy soliciting materials - definitive in HTML.Open Additional proxy soliciting materials - definitive in DOC file.Open Additional proxy soliciting materials - definitive in PDF file.Open Additional proxy soliciting materials - definitive in XLS file.
10-KAnnual report which provides a comprehensive overview of the company for the past yearMar 20, 2001Open Annual report which provides a comprehensive overview of the company for the past year in HTML.Open Annual report which provides a comprehensive overview of the company for the past year in DOC file.Open Annual report which provides a comprehensive overview of the company for the past year in PDF file.Open Annual report which provides a comprehensive overview of the company for the past year in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2001Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 14, 2001Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2001Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
424B2Form of prospectus filed in connection with primary offering of securities on a delayed basisJan 31, 2001Open Form of prospectus filed in connection with primary offering of securities on a delayed basis in HTML.Open Form of prospectus filed in connection with primary offering of securities on a delayed basis in DOC file.Open Form of prospectus filed in connection with primary offering of securities on a delayed basis in PDF file.Open Form of prospectus filed in connection with primary offering of securities on a delayed basis in XLS file.
S-3/APre-effective amendment to an S-3 filingJan 29, 2001Open Pre-effective amendment to an S-3 filing in HTML.Open Pre-effective amendment to an S-3 filing in DOC file.Open Pre-effective amendment to an S-3 filing in PDF file.Open Pre-effective amendment to an S-3 filing in XLS file.
S-3/APre-effective amendment to an S-3 filingJan 11, 2001Open Pre-effective amendment to an S-3 filing in HTML.Open Pre-effective amendment to an S-3 filing in DOC file.Open Pre-effective amendment to an S-3 filing in PDF file.Open Pre-effective amendment to an S-3 filing in XLS file.
1-25      26-35

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information